[go: up one dir, main page]

EP0537247A4 - Nonpathogenic variant virus - Google Patents

Nonpathogenic variant virus

Info

Publication number
EP0537247A4
EP0537247A4 EP19910912526 EP91912526A EP0537247A4 EP 0537247 A4 EP0537247 A4 EP 0537247A4 EP 19910912526 EP19910912526 EP 19910912526 EP 91912526 A EP91912526 A EP 91912526A EP 0537247 A4 EP0537247 A4 EP 0537247A4
Authority
EP
European Patent Office
Prior art keywords
variant virus
nonpathogenic variant
nonpathogenic
virus
variant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19910912526
Other versions
EP0537247A1 (en
Inventor
George Pieczenik
Michael Scolaro
Roy Durham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IMMUVAX
Original Assignee
IMMUVAX
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IMMUVAX filed Critical IMMUVAX
Publication of EP0537247A1 publication Critical patent/EP0537247A1/en
Publication of EP0537247A4 publication Critical patent/EP0537247A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/21Retroviridae, e.g. equine infectious anemia virus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00Reverse transcribing RNA viruses
    • C12N2740/00011Details
    • C12N2740/10011Retroviridae
    • C12N2740/16011Human Immunodeficiency Virus, HIV
    • C12N2740/16034Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP19910912526 1990-06-19 1991-06-19 Nonpathogenic variant virus Withdrawn EP0537247A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US54052990A 1990-06-19 1990-06-19
US540529 1990-06-19
US62595890A 1990-12-11 1990-12-11
US625958 1990-12-11

Publications (2)

Publication Number Publication Date
EP0537247A1 EP0537247A1 (en) 1993-04-21
EP0537247A4 true EP0537247A4 (en) 1993-09-08

Family

ID=27066463

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19910912526 Withdrawn EP0537247A4 (en) 1990-06-19 1991-06-19 Nonpathogenic variant virus

Country Status (3)

Country Link
EP (1) EP0537247A4 (en)
CA (1) CA2085897A1 (en)
WO (1) WO1991019795A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6015661A (en) * 1994-02-14 2000-01-18 The Macfarlane Burnet Centre For Medical Research Limited Methods for the detection of non-pathogenic HIV-1 strains containing deletions in the Nef coding region and U3 region of the LTR
AU699175B2 (en) * 1994-02-14 1998-11-26 Australian Red Cross Society (Nsw Division) Non-pathogenic strains of HIV-1
IL112636A0 (en) * 1994-02-14 1995-05-26 Macfarlane Burnet Ctre Med Res Non-pathogenic strains of hiv-1
TWI239847B (en) 1997-12-02 2005-09-21 Elan Pharm Inc N-terminal fragment of Abeta peptide and an adjuvant for preventing and treating amyloidogenic disease
US20080050367A1 (en) 1998-04-07 2008-02-28 Guriq Basi Humanized antibodies that recognize beta amyloid peptide
US7964192B1 (en) 1997-12-02 2011-06-21 Janssen Alzheimer Immunotherapy Prevention and treatment of amyloidgenic disease
MY139983A (en) 2002-03-12 2009-11-30 Janssen Alzheimer Immunotherap Humanized antibodies that recognize beta amyloid peptide
WO2006066089A1 (en) 2004-12-15 2006-06-22 Neuralab Limited Humanized amyloid beta antibodies for use in improving cognition
US8784810B2 (en) 2006-04-18 2014-07-22 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases
US8003097B2 (en) 2007-04-18 2011-08-23 Janssen Alzheimer Immunotherapy Treatment of cerebral amyloid angiopathy
ES2498040T3 (en) 2007-07-27 2014-09-24 Janssen Alzheimer Immunotherapy Treatment of amyloidogenic diseases with humanized anti-beta antibodies
JO3076B1 (en) 2007-10-17 2017-03-15 Janssen Alzheimer Immunotherap Immunotherapy regimes dependent on apoe status
US9067981B1 (en) 2008-10-30 2015-06-30 Janssen Sciences Ireland Uc Hybrid amyloid-beta antibodies

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU594444B2 (en) * 1986-02-14 1990-03-08 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Plasmids which inhibit human t-cell lymphotropic virus type iii replication
EP0242216A1 (en) * 1986-04-16 1987-10-21 THE UNITED STATES OF AMERICA as represented by the Secretary United States Department of Commerce Non-cytopathic clone of Human T-Cell Lymphotropic Virus type III
JPH01120284A (en) * 1987-11-05 1989-05-12 Shiro Kato Incomplete particle of hiv and production thereof
IL89567A0 (en) * 1988-03-28 1989-09-10 Univ Leland Stanford Junior Mutated hiv envelope protein
JPH02203783A (en) * 1989-02-02 1990-08-13 Banyu Pharmaceut Co Ltd Cloned human t cell forming non-virulent aids virus having antigenicity

Also Published As

Publication number Publication date
WO1991019795A1 (en) 1991-12-26
EP0537247A1 (en) 1993-04-21
CA2085897A1 (en) 1991-12-20

Similar Documents

Publication Publication Date Title
AU111085S (en) Sunlounger
GB2248044B (en) Improved doll-carriages
HU910958D0 (en) Bacteria-vectors
EP0448099A3 (en) Novel peptides
GB9102066D0 (en) An improved ozonier
EP0537247A4 (en) Nonpathogenic variant virus
AU110900S (en) Facsimilie
CS262591A3 (en) Indolonaphthyridines
GB2272483B (en) Stays
GB2249343B (en) Stays
ZA915978B (en) Peptides
GB2248607B (en) Improved fishbox
GB9005419D0 (en) Improved depanner
AU109294S (en) Listello
GB9100998D0 (en) Boardgame
GB9007724D0 (en) Novel piperidin-4-spiro-oxiranes
GB9020800D0 (en) Virus attenuation
CA66168S (en) Récipient
CA65360S (en) Stomatologic electroanesthetizer
CA65836S (en) Attache-case
GB9028140D0 (en) Peptides
GB9013944D0 (en) Improved airfreshener
SG24194G (en) Improved fishbox
GB9105801D0 (en) Instant photograph-postcard
GB9103366D0 (en) Instant photograph-postcard

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19930118

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19930720

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IT LI LU NL SE

17Q First examination report despatched

Effective date: 19950316

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19960101